Sort by

Send to

Choose Destination

Search results

Items: 3


The influence of salivary amylase on total amylase elevation in CML patients treated with TKI therapy: a case series of 3 patients.

Nesr G, Claudiani S, Khorashad J, Apperley J, Milojkovic D.

Leuk Lymphoma. 2019 Jun 22:1-2. doi: 10.1080/10428194.2019.1627536. [Epub ahead of print] No abstract available.


T-cell prolymphocytic leukaemia in a patient with chronic myeloid leukaemia receiving nilotinib: first documented report.

Hanley B, Nesr G, Yebra-Fernandez E, Brown L, Rabitsch A, Killeen N, Claudiani S, Milojkovic D, Kanfer E, Apperley J, Naresh KN.

J Clin Pathol. 2019 Jul;72(7):511-512. doi: 10.1136/jclinpath-2019-205799. Epub 2019 Apr 19. No abstract available.


MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia.

Claudiani S, Gatenby A, Szydlo R, Nesr G, Abulafia AS, Palanicawandar R, Nteliopoulos G, Khorashad J, Foroni L, Apperley JF, Milojkovic D.

Haematologica. 2019 Nov;104(11):2206-2214. doi: 10.3324/haematol.2018.214809. Epub 2019 Mar 28.

Supplemental Content

Support Center